Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

54.89
-0.3100-0.56%
Post-market: 54.80-0.0900-0.16%19:52 EDT
Volume:3.10M
Turnover:169.55M
Market Cap:10.61B
PE:144.83
High:54.97
Open:54.95
Low:53.90
Close:55.20
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:1.24
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:1.68
PE(LYR):30.49

Loading ...

May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 28, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 06, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 06, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 21, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2022

Major Issues Report

8-K - Current report